{"filing":{"accession_number":"0001493152-26-047770","cik":"0001857044","ticker":"INDP","company_name":"Indaptus Therapeutics, Inc.","form":"8-K","filing_date":"2026-10-20","report_date":"2026-10-16","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226047770/form8-k.htm"},"events":[{"id":36457,"run_id":33615,"accession_number":"0001493152-26-047770","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses completion of a private placement of 20,338,974 shares of common stock for approximately $24.0 million in gross proceeds. This is an unregistered equity issuance that materially dilutes existing shareholders and represents a significant capital raise for the company, meeting the definition of dilutive_issuance.","company_name":"Indaptus Therapeutics, Inc.","ticker":"INDP","filing_date":"2026-10-20","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":40874,"accession_number":"0001493152-26-047770","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses completion of a private placement of 20,338,974 shares of common stock for approximately $24.0 million in gross proceeds. This is an unregistered equity issuance that materially dilutes existing shareholders and represents a significant capital raise for the company, meeting the definition of dilutive_issuance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-10-20T20:39:36.136228+00:00","company_name":"Indaptus Therapeutics, Inc.","ticker":"INDP","filing_date":"2026-10-20"}]}